Advanced Medical Isotope Research and Development Expenses 2013-2025 | RDGL

Advanced Medical Isotope research and development expenses from 2013 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.

Advanced Medical Isotope Research and Development Expenses 2013-2025 | RDGL

Advanced Medical Isotope research and development expenses from 2013 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
Related Stocks
Company NameMarket
Cap
Ares Capital (ARCC)$14B
Blackstone Secured Lending Fund (BXSL)$6.6B
FS KKR Capital (FSK)$5.5B
Main Street Capital (MAIN)$4.7B
Golub Capital BDC (GBDC)$3.8B
Hercules Capital (HTGC)$3.1B
Sixth Street Specialty Lending (TSLX)$1.9B
Morgan Stanley Direct Lending Fund (MSDL)$1.7B
Goldman Sachs BDC (GSBD)$1.2B
Kayne Anderson BDC (KBDC)$1.1B
New Mountain Finance (NMFC)$1.1B
Bain Capital Specialty Finance (BCSF)$967M
BARINGS BDC, INC (BBDC)$917M
Trinity Capital (TRIN)$900M
Amalgamated Financial (AMAL)$820M
Nuveen Churchill Direct Lending (NCDL)$777M
Carlyle Secured Lending (CGBD)$743M
Fidus Investment (FDUS)$644M
BLACKROCK TCP CAPITAL CORP (TCPC)$578M
Crescent Capital BDC (CCAP)$574M
Gladstone Capital (GLAD)$556M
Gladstone Investment (GAIN)$512M
CION Investment (CION)$501M
Palmer Square Capital BDC (PSBD)$418M
PennantPark Investment (PNNT)$413M
Stellus Capital Investment (SCM)$351M
Runway Growth Finance (RWAY)$343M
Horizon Technology Finance (HRZN)$338M
Saratoga Investment Corp (SAR)$337M
TriplePoint Venture Growth BDC (TPVG)$240M